Bacterial coinfection among coronavirus disease 2019 patient groups: an updated systematic review and meta-analysis

The pandemic of severe acute respiratory syndrome coronavirus 2 raised the attention towards bacterial coinfection and its role in coronavirus disease 2019 (COVID-19) disease. This study aims to systematically review and identify the pooled prevalence of bacterial coinfection in the related articles...

Full description

Bibliographic Details
Main Authors: S. Soltani, S. Faramarzi, M. Zandi, R. Shahbahrami, A. Jafarpour, S. Akhavan Rezayat, I. Pakzad, F. Abdi, P. Malekifar, R. Pakzad
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:New Microbes and New Infections
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2052297521000743
id doaj-f63e4742f9f34d34b95842630a95d707
record_format Article
spelling doaj-f63e4742f9f34d34b95842630a95d7072021-10-01T04:56:23ZengElsevierNew Microbes and New Infections2052-29752021-09-0143100910Bacterial coinfection among coronavirus disease 2019 patient groups: an updated systematic review and meta-analysisS. Soltani0S. Faramarzi1M. Zandi2R. Shahbahrami3A. Jafarpour4S. Akhavan Rezayat5I. Pakzad6F. Abdi7P. Malekifar8R. Pakzad9Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, IranRazi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, IranDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, IranResearch Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, IranResearch Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran; Gerash Amir-al-Momenin Medical and Educational Center, Gerash University of Medical Sciences, Gerash, IranDepartment of Management & Health Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, IranMedical Microbiology, Department of Microbiology, School of Medicine, Ilam University Medical Sciences, Ilam, IranSchool of Nursing and Midwifery, Alborz University of Medical Sciences, Karaj, IranEpidemiology, Department of Epidemiology, School of Public Health, Tehran University Medical Sciences, Tehran, Iran; Corresponding author: P. Malekifar, Department of Epidemiology, School of Public Health, Tehran University of Medical Sciences, Poursina Street, PO Box: 6446-14155, Tehran, IranEpidemiology, Department of Epidemiology, Faculty of Health, Ilam University Medical Sciences, Ilam, Iran; Student Research Committee, Ilam University Medical Sciences, Ilam, Iran; Corresponding author: R. Pakzad, Department of Epidemiology, Faculty of Health, Ilam University Medical Sciences, Banganjab, Ilam, IranThe pandemic of severe acute respiratory syndrome coronavirus 2 raised the attention towards bacterial coinfection and its role in coronavirus disease 2019 (COVID-19) disease. This study aims to systematically review and identify the pooled prevalence of bacterial coinfection in the related articles. A comprehensive search was conducted in international databases, including MEDLINE, Scopus, Web of Science, and Embase, to identify the articles on the prevalence of bacterial coinfections in COIVD-19 patients from 1 December 2019 until 30 December 2020. All observational epidemiological studies that evaluated the prevalence of bacterial coinfections in patients with COVID-19 were included without any restriction. Forty-two studies including a total sample size of 54,695 were included in the analysis. The pooled estimate for the prevalence of bacterial coinfections was 20.97% (95% CI: 15.95–26.46), and the pooled prevalence of bacterial coinfections was 5.20% (95% CI: 2.39–8.91) for respiratory subtype and 4.79% (95% CI: 0.11–14.61) for the gastrointestinal subtype. The pooled prevalence for Eastern Mediterranean Regional Office and South-East Asia Regional Office was 100% (95% CI: 82.35–100.00) and 2.61% (95% CI: 1.74–3.62). This rate of coinfection poses a great danger towards patients, especially those in critical condition. Although there are multiple complications and adverse effects related to extensive use of antibiotics to treat patients with COVID-19, it seems there is no other option except applying them, and it needs to be done carefully.http://www.sciencedirect.com/science/article/pii/S2052297521000743CoinfectioncoronavirusCOVID-19meta-analysissystematics review
collection DOAJ
language English
format Article
sources DOAJ
author S. Soltani
S. Faramarzi
M. Zandi
R. Shahbahrami
A. Jafarpour
S. Akhavan Rezayat
I. Pakzad
F. Abdi
P. Malekifar
R. Pakzad
spellingShingle S. Soltani
S. Faramarzi
M. Zandi
R. Shahbahrami
A. Jafarpour
S. Akhavan Rezayat
I. Pakzad
F. Abdi
P. Malekifar
R. Pakzad
Bacterial coinfection among coronavirus disease 2019 patient groups: an updated systematic review and meta-analysis
New Microbes and New Infections
Coinfection
coronavirus
COVID-19
meta-analysis
systematics review
author_facet S. Soltani
S. Faramarzi
M. Zandi
R. Shahbahrami
A. Jafarpour
S. Akhavan Rezayat
I. Pakzad
F. Abdi
P. Malekifar
R. Pakzad
author_sort S. Soltani
title Bacterial coinfection among coronavirus disease 2019 patient groups: an updated systematic review and meta-analysis
title_short Bacterial coinfection among coronavirus disease 2019 patient groups: an updated systematic review and meta-analysis
title_full Bacterial coinfection among coronavirus disease 2019 patient groups: an updated systematic review and meta-analysis
title_fullStr Bacterial coinfection among coronavirus disease 2019 patient groups: an updated systematic review and meta-analysis
title_full_unstemmed Bacterial coinfection among coronavirus disease 2019 patient groups: an updated systematic review and meta-analysis
title_sort bacterial coinfection among coronavirus disease 2019 patient groups: an updated systematic review and meta-analysis
publisher Elsevier
series New Microbes and New Infections
issn 2052-2975
publishDate 2021-09-01
description The pandemic of severe acute respiratory syndrome coronavirus 2 raised the attention towards bacterial coinfection and its role in coronavirus disease 2019 (COVID-19) disease. This study aims to systematically review and identify the pooled prevalence of bacterial coinfection in the related articles. A comprehensive search was conducted in international databases, including MEDLINE, Scopus, Web of Science, and Embase, to identify the articles on the prevalence of bacterial coinfections in COIVD-19 patients from 1 December 2019 until 30 December 2020. All observational epidemiological studies that evaluated the prevalence of bacterial coinfections in patients with COVID-19 were included without any restriction. Forty-two studies including a total sample size of 54,695 were included in the analysis. The pooled estimate for the prevalence of bacterial coinfections was 20.97% (95% CI: 15.95–26.46), and the pooled prevalence of bacterial coinfections was 5.20% (95% CI: 2.39–8.91) for respiratory subtype and 4.79% (95% CI: 0.11–14.61) for the gastrointestinal subtype. The pooled prevalence for Eastern Mediterranean Regional Office and South-East Asia Regional Office was 100% (95% CI: 82.35–100.00) and 2.61% (95% CI: 1.74–3.62). This rate of coinfection poses a great danger towards patients, especially those in critical condition. Although there are multiple complications and adverse effects related to extensive use of antibiotics to treat patients with COVID-19, it seems there is no other option except applying them, and it needs to be done carefully.
topic Coinfection
coronavirus
COVID-19
meta-analysis
systematics review
url http://www.sciencedirect.com/science/article/pii/S2052297521000743
work_keys_str_mv AT ssoltani bacterialcoinfectionamongcoronavirusdisease2019patientgroupsanupdatedsystematicreviewandmetaanalysis
AT sfaramarzi bacterialcoinfectionamongcoronavirusdisease2019patientgroupsanupdatedsystematicreviewandmetaanalysis
AT mzandi bacterialcoinfectionamongcoronavirusdisease2019patientgroupsanupdatedsystematicreviewandmetaanalysis
AT rshahbahrami bacterialcoinfectionamongcoronavirusdisease2019patientgroupsanupdatedsystematicreviewandmetaanalysis
AT ajafarpour bacterialcoinfectionamongcoronavirusdisease2019patientgroupsanupdatedsystematicreviewandmetaanalysis
AT sakhavanrezayat bacterialcoinfectionamongcoronavirusdisease2019patientgroupsanupdatedsystematicreviewandmetaanalysis
AT ipakzad bacterialcoinfectionamongcoronavirusdisease2019patientgroupsanupdatedsystematicreviewandmetaanalysis
AT fabdi bacterialcoinfectionamongcoronavirusdisease2019patientgroupsanupdatedsystematicreviewandmetaanalysis
AT pmalekifar bacterialcoinfectionamongcoronavirusdisease2019patientgroupsanupdatedsystematicreviewandmetaanalysis
AT rpakzad bacterialcoinfectionamongcoronavirusdisease2019patientgroupsanupdatedsystematicreviewandmetaanalysis
_version_ 1716862287398043648